Effect of the novel senolytic drug, BCL-xL PROTAC, on small airway epithelial cells in COPD

Justine Devulder; Peter Fenwick; May Al Sahaf; Patrizia Viola; Neetu Razdan; Raphaël Lemaire; Lina Odqvist; Louise Donnelly; Peter J Barnes

doi:10.1183/13993003.congress-2024.pa4429

Related publications

Article2025

Effect of the novel senolytic drug, BCL-xL-PROTAC, on small airway fibroblasts in COPD

Justine Devulder, Peter Fenwick, May Al‐Sahaf, Patrizia Viola, Neetu Razdan, Raphaël Lemaire, Lina Odqvist, Louise Donnelly, Peter J Barnes

Article2024

Effect of the putative senotherapy, Fisetin on small airway epithelial cells in COPD

Justine Devulder, Peter Fenwick, May Al Sahaf, Patrizia Viola, Louise Donnelly, Peter J Barnes

Article2025

BCLXL-PROTAC as a senolytic therapy in COPD alveolar type II cells

Yiling Guo, Peter Fenwick, Louise Donnelly, Peter J Barnes

Article2020

Altered iron metabolism and elevated cellular senescence in COPD small airway epithelial cells

Jonathan Baker, Peter Fenwick, Louise Donnelly, Peter J Barnes, Suzanne M. Cloonan

Article2014

Radiosensitization by a novel Bcl-2 and Bcl-XL inhibitor S44563 in small-cell lung cancer

Yohann Loriot, Pierre Mordant, Delphine Dugué, Olivier Geneste, Andrea Gombos, Paule Opolon, Jean‐François Guégan, Jean‐Luc Perfettini, Alain Pierré, L. Kraus Berthier, Guido Guido Kroemer, Jean‐Charles Soria, Stéphane Depil, Éric Deutsch